Ivabradine and Outcomes in Chronic Heart Failure (SHIFT): A Randomised Placebo-Controlled Study
Chronic heart failure affects roughly 2–3% of the population in many industrialised countries.
Chronic heart failure affects roughly 2–3% of the population in many industrialised countries.
An elevated resting heart rate (HR) is a known risk marker and likely risk factor for adverse outcomes in patients with heart failure (HF).
Diabetes mellitus and chronic heart failure (HF), both common conditions increasing in prevalence as the general population ages, are significant burdens to public health.
The cardiomyopathy caused by Chagas disease (ChD) is a major cause of morbidity and mortality in Latin America.
ESC Congress focuses on the best and latest science with renowned leaders in cardiovascular medicine. With more than 30,000 delegates – it is the largest such gathering in the world…
ESC Congress focuses on the best and latest science with renowned leaders in cardiovascular medicine. With more than 30,000 delegates – it is the largest such gathering in the world…